Skip to content

The Effect of Narrative Therapy-Based Counseling on Pregnancy-Related Anxiety among Adolescent Pregnant Women: A Randomized Controlled Clinical Trial

The Effect of Narrative Therapy on Pregnancy-Related Anxiety among Adolescent Pregnant Women

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20220926056046N6
Enrollment
62
Registered
2025-11-17
Start date
2025-11-22
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Pregnancy-related anxiety. Condition 2: Pregnancy adoptation. Condition 3: Prenatal Depression. Condition 4: Quality of life during pregnancy.

Interventions

Intervention 1: Intervention group: The intervention group will receive six group counseling sessions based on a narrative therapy approach, each lasting 45–60 minutes. The first session will be condu

Sponsors

Tabriz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
10 Years to 19 Years

Inclusion criteria

Inclusion criteria: Residence in Tabriz or the surrounding areas Maternal age between 10 and 19 years Gestational age between 20 and 26 weeks A score higher than 22 based on the Pregnancy Anxiety Questionnaire (63) Having elementary education Possession of a smartphone

Exclusion criteria

Exclusion criteria: Presence of a known fetal anomaly based on ultrasound report Pregnancy complicated by conditions such as a history of recurrent miscarriage, multiple pregnancy, gestational diabetes, hypertension, maternal cardiac disease, renal disease, antepartum hemorrhage, history of preterm delivery, placenta previa, intrauterine growth restriction (IUGR), infections such as HIV and hepatitis, pregnancy resulting from IVF, or Rh incompatibility History of depression based on maternal self-report or medical record review A score of 13 or higher on the Edinburgh Postnatal Depression Scale (EPDS) or a positive response to the suicide item Hearing impairment or inability to speak Use of antidepressant medications during pregnancy Experience of a major stressful life event, such as the death or diagnosis of a life-threatening illness in a first-degree relative, within three months prior to data collection Presence of severe anxiety according to the Anxiety Questionnaire (scores above 40) and confirmed by clinical psychologist interview

Design outcomes

Primary

MeasureTime frame
Pregnancy-related anxiety. Timepoint: Assessment of pregnancy-related anxiety before the intervention and four weeks after the completion of the intervention sessions. Method of measurement: Pregnancy-related anxiety will be assessed using the Revised Pregnancy-Related Anxiety Questionnaire (R-PRAQ) short form.

Secondary

MeasureTime frame
Adaptation to Pregnancy. Timepoint: Adaptation to pregnancy will be assessed before the start of the intervention and four weeks after the completion of the intervention sessions. Method of measurement: Adaptation to pregnancy will be measured using the revised version of the Pregnancy Coping Inventory (PCI).;Prenatal Depression. Timepoint: Prenatal Depression will be assessed before the start of the intervention and four weeks after the completion of the intervention sessions. Method of measurement: Prenatal Depression will be measured using the (EPDS=Edinburgh Postpartum Depression Scale).;Quality of life in pregnancy. Timepoint: Quality of life in pregnancy will be assessed before the start of the intervention and four weeks after the completion of the intervention sessions. Method of measurement: Quality of life in pregnancy will be measured using the (Quality of life-Gravity=QOL-GRAV).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSolmaz Ghanbari Homaie

Tabriz University of Medical Sciences

homayisolmaz@gmail.com+98 41 3477 0648

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026